A Practical Approach to the Diagnosis of Primary Aldosteronism

By DocWire News Editors - Last Updated: August 22, 2018

Primary aldosteronism (PA) is the most common form of secondary hypertension. Interesting enough, when compared with primary hypertension, PA causes more end-organ damage and is associated with excess cardiovascular morbidity, including heart failure, stroke, nonfatal myocardial infarction, and atrial fibrillation. Although screening opportunities are available, the screening rates for PA are low. In a study published by Circulation, researchers discuss a practical approach to PA screening and that any clinician that treats hypertension should routinely screen appropriate patients for PA. 

Advertisement

According to the study, primary aldosteronism is defined as “inappropriately elevated aldosterone production in the setting of low plasma renin.” Originally, PA was thought to be rare but is now known to be the most common cause of secondary hypertension. Early identification of PA is essential in order to appropriately and specifically treat itbut PA remains underrecognized by both internists and specialists. 

The study states that out of U.S. patients with primary aldosteronism, 1 in 550 is actually diagnosed and treated for the condition and shows the issue with underdiagnosis. However, a recent expansion of knowledge has addressed the prevalence, pathophysiology, and the clinical approach to PA. In turn, this has provided an evidence-based understanding of this common condition. 

Check out an article on the concerns of using of epinephrine as a treatment for out-of-hospital cardiac arrest. 

SOURCE: Circulation 

Advertisement
Advertisement
Advertisement